An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples